Ceruloplasmin is a copper-carrying protein made primarily by the liver and released into the bloodstream, where it accounts for the vast majority of circulating copper. Doctors order a ceruloplasmin blood test most often when they suspect a disorder of copper metabolism, but levels also shift in response to inflammation, hormonal changes, and several chronic diseases. The protein’s name comes from the Latin word for “sky blue,” a nod to the blue color copper gives it in concentrated form. Understanding what drives ceruloplasmin up or down helps make sense of a test result that, on its own, rarely tells the whole story.
What Ceruloplasmin Actually Does
Ceruloplasmin is a large protein that binds six or seven copper atoms within its structure. Research on how copper gets loaded into the molecule has shown that disrupting even a single copper-binding site prevents the protein from incorporating copper at all, suggesting the loading process is tightly coordinated rather than piecemeal.1Journal of Biological Chemistry. Mechanisms of Copper Incorporation into Human Ceruloplasmin That copper cargo is not just along for the ride. It powers the protein’s most important job: acting as a ferroxidase, an enzyme that converts iron from one chemical form to another so the body can move it where it needs to go.
Iron in your blood needs to be in its oxidized form to bind transferrin, the shuttle protein that delivers iron to cells throughout the body. Ceruloplasmin handles that conversion. Without it, iron gets stuck in a form cells struggle to use, and it begins to pile up in tissues instead of cycling properly. Studies have confirmed that ceruloplasmin’s ferroxidase activity is essential for stimulating cellular iron uptake and that ferroxidase-defective versions of the protein are completely inactive in this role.2Journal of Biological Chemistry. Ceruloplasmin Ferroxidase Activity Stimulates Cellular Iron Uptake by a Trivalent Cation-specific Transport Mechanism The same oxidation step is also necessary for iron to bind ferritin, the main storage protein.3Postępy Higieny i Medycyny Doświadczonej. Ceruloplasmin, hephaestin and zyklopen: the three multicopper oxidases important for human iron metabolism
Beyond iron handling, ceruloplasmin moonlights as an antioxidant. It scavenges several types of free radicals independently of its ferroxidase activity. Experimental comparisons found it far more effective at neutralizing peroxyl radicals than several other well-known antioxidant molecules, and it also scavenges superoxide and hydroxyl radicals.4Molecular and Cellular Biochemistry. Direct evidence of ceruloplasmin antioxidant properties This antioxidant role helps explain why the body ramps up ceruloplasmin production during illness and injury, when oxidative stress is at its peak.
Ceruloplasmin as an Acute-Phase Reactant
Your body treats ceruloplasmin as an acute-phase reactant, meaning the liver cranks out more of it whenever there is significant inflammation. The signaling molecule interleukin-6, one of the main drivers of the inflammatory response, can boost ceruloplasmin gene expression in liver cells roughly fivefold.5PubMed. Dual role of insulin in transcriptional regulation of the acute phase reactant ceruloplasmin This is why a single elevated ceruloplasmin result does not point to one specific disease. Infections, autoimmune flares, tissue injury, surgery, and even intense physical stress all provoke the same inflammatory cascade that pushes ceruloplasmin higher.
This acute-phase behavior creates a diagnostic headache. A person with early Wilson disease (which normally causes low ceruloplasmin) who also has an active liver inflammation could show a “normal” ceruloplasmin level because the inflammatory rise masks the genetic deficiency. A doctor interpreting the result in isolation might miss the underlying disorder entirely.
Why Ceruloplasmin Levels Drop
Low ceruloplasmin is not synonymous with any single diagnosis. It shows up across a surprisingly wide range of conditions, from rare genetic disorders to straightforward nutritional shortfalls. The causes fall into two broad camps: genetic problems that impair how the body makes or loads copper into ceruloplasmin, and acquired conditions where something else reduces the protein’s production or increases its loss.
Wilson Disease
Wilson disease is the most clinically significant reason to test ceruloplasmin. It is an inherited disorder caused by mutations in the ATP7B gene, which codes for a copper-transporting protein in the liver. When ATP7B does not work properly, copper cannot be loaded into ceruloplasmin or excreted into bile. The result is a double hit: ceruloplasmin levels in the blood fall because the protein is secreted without its copper cargo (and is rapidly broken down in that empty form), while copper accumulates to toxic levels in the liver, brain, and other organs. More than 600 different mutations in ATP7B have been identified.6PubMed Central. The genetics of Wilson disease
In children being evaluated for Wilson disease, ceruloplasmin testing performs well as a screening tool. One large study of over 2,800 children with hepatitis found that a cutoff around 16 to 17 mg/dL yielded sensitivity above 91% and specificity close to 95%.7PubMed Central. Diagnostic Value of Ceruloplasmin in the Diagnosis of Pediatric Wilson’s Disease A separate study in children placed the optimal cutoff at 15 mg/dL and reported similarly strong diagnostic accuracy.8PubMed Central. A cross-sectional assessment of the diagnostic value of serum ceruloplasmin for Wilson’s disease in children Still, false positives and false negatives happen often enough that ceruloplasmin alone is never sufficient to confirm or rule out Wilson disease. Doctors combine it with 24-hour urine copper, genetic testing, liver biopsy findings, and a clinical exam looking for Kayser-Fleischer rings in the eyes.
Menkes Disease
Menkes disease is a different genetic copper disorder, this one X-linked, meaning it primarily affects boys. The problem here is in the ATP7A gene, which controls copper absorption from the gut. Copper simply cannot get into the bloodstream efficiently, so both serum copper and ceruloplasmin are low. The consequences are severe, including neurological deterioration, seizures, and connective tissue abnormalities, and symptoms typically appear in infancy.9PubMed. Menkes disease, a diagnosis to consider in case of severe epilepsy with hyperlactacidemia Unlike Wilson disease, the problem in Menkes is copper deficiency in tissues rather than copper overload.
Aceruloplasminemia
Aceruloplasminemia is among the rarest causes of low ceruloplasmin. Mutations in the ceruloplasmin gene itself leave the body unable to produce a functional protein. Without ceruloplasmin’s ferroxidase activity, iron accumulates in the brain, liver, and pancreas. Symptoms tend to appear in adulthood and include neurodegeneration, diabetes from pancreatic iron deposits, and retinal degeneration.10PubMed Central. Neurodegeneration With Brain Iron Accumulation in a Case of Adult Aceruloplasminemia The iron overload in aceruloplasminemia is a vivid demonstration of how important ceruloplasmin’s iron-handling function really is.
Acquired Causes of Low Levels
You do not need a genetic mutation to end up with low ceruloplasmin. Malabsorption syndromes, severe protein loss through the kidneys or gut (protein-losing enteropathy), chronic liver disease that impairs the liver’s synthetic capacity, and simple copper deficiency from poor nutrition or prolonged zinc supplementation can all pull levels down.11Irish Medical Journal. Serum Ceruloplasmin Measurement in Clinical Practice: A 7-Year Single Centre Experience Among these, copper deficiency from excessive zinc intake deserves special mention because it is iatrogenic: people taking high-dose zinc supplements for immune support or other reasons can inadvertently block copper absorption and drive ceruloplasmin into the low range.
Why Ceruloplasmin Levels Rise
Elevated ceruloplasmin is far more common than low levels and, on its own, is rarely a surprise finding that sends doctors scrambling. Because of the acute-phase response described earlier, any significant inflammation can push the number up. But certain conditions are especially associated with high readings.
Inflammatory and Autoimmune Diseases
Chronic inflammatory conditions reliably elevate ceruloplasmin. In rheumatoid arthritis, for example, ceruloplasmin concentrations are significantly higher than in healthy controls, and the degree of elevation correlates with markers of disease activity like the erythrocyte sedimentation rate.12Annals of Agricultural and Environmental Medicine. Copper levels in patients with rheumatoid arthritis Similar rises occur in lupus, inflammatory bowel disease, and chronic infections. The increase reflects the liver responding to ongoing inflammatory signaling rather than anything specific to the joint, gut, or other affected tissue.
Estrogen and Oral Contraceptives
Estrogen stimulates the liver to produce more ceruloplasmin. This is why levels naturally rise during pregnancy and in people taking combination oral contraceptives. A meta-analysis pooling data from 26 studies found that combination oral contraceptive use raises serum copper by about 0.57 mg/L on average, commonly pushing levels to 1.5 to 2 mg/L, which is above standard reference ranges.13Contraception. Blood copper levels in combination oral contraceptive users: A systematic review and meta-analysis Since most circulating copper is bound to ceruloplasmin, these elevated copper levels directly reflect elevated ceruloplasmin. The rise is pharmacological, not pathological, and reverses after stopping the medication. Doctors who are aware of this avoid misinterpreting an elevated ceruloplasmin in a person taking hormonal contraception.
Cancer
Ceruloplasmin tends to rise in advanced malignancies. Research has shown significantly elevated levels in patients with advanced-stage solid tumors, with locally spreading cancers also producing meaningful increases.14Cancer Letters. Serum ceruloplasmin as a diagnostic marker of cancer Studies in bile duct cancer have found strong ceruloplasmin expression in tumors with advanced staging and perineural invasion.15PubMed Central. Ceruloplasmin as a prognostic marker in patients with bile duct cancer No one uses ceruloplasmin as a standalone cancer screening test, but oncologists sometimes track it alongside other markers when monitoring disease progression or treatment response.
The Antioxidant That Can Also Cause Damage
One of the more counterintuitive aspects of ceruloplasmin is that the same molecule can act as both a protector and a destroyer, depending on its structural state. Intact ceruloplasmin scavenges free radicals and prevents oxidative damage. But when the protein loses even a single copper atom or undergoes specific structural changes, it flips to a pro-oxidant role and can oxidize LDL cholesterol, the so-called “bad cholesterol.”16PubMed. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin Oxidized LDL is a key driver of atherosclerotic plaque formation.
The pro-oxidant activity appears to depend on a specific surface copper atom near one particular region of the protein, and the reaction is enhanced when superoxide radicals are around to reduce that copper.17Free Radical Biology and Medicine. Ceruloplasmin and cardiovascular disease This dual personality has drawn attention in cardiovascular research. A systematic review examining ceruloplasmin and coronary heart disease noted that the protein can decrease nitric oxide availability in plasma through its oxidase activity, and nitric oxide is crucial for healthy blood vessel function.18PubMed Central. Ceruloplasmin and Coronary Heart Disease—A Systematic Review The relationship between elevated ceruloplasmin and heart disease risk remains an area of active investigation, with inflammation being the obvious confounder: the same conditions that raise ceruloplasmin also raise cardiovascular risk through dozens of other pathways.
How the Test Is Done and Where It Can Mislead
Most hospital labs measure ceruloplasmin using an immunological assay, which detects the protein itself regardless of whether it is loaded with copper and enzymatically active. The alternative is an enzymatic assay that measures the protein’s oxidase activity, the actual functional capacity. These two methods do not always agree, and the discrepancy matters clinically. A study comparing the approaches in patients being evaluated for Wilson disease found a strong correlation between protein concentration and enzyme activity in healthy controls, but the correlation broke down in patients with liver or neurological symptoms. Roughly 8% of neurological patients had normal ceruloplasmin protein concentrations but low enzymatic activity, meaning the standard immunological test would have missed a potentially significant abnormality.19PubMed. Value of an enzymatic assay for the determination of serum ceruloplasmin
The practical implication is that a “normal” ceruloplasmin result on a standard blood panel does not always mean normal ceruloplasmin function. If a doctor has a strong clinical suspicion of Wilson disease or another copper disorder, the enzymatic assay provides more biologically meaningful information. Most routine clinical labs default to the immunological method because it is simpler and cheaper, so patients being worked up for copper disorders may need testing at a reference laboratory.
Normal reference ranges for ceruloplasmin in adults generally fall between about 20 and 35 mg/dL, though exact cutoffs vary by lab and method. Newborns and young infants have physiologically low ceruloplasmin that rises over the first few months of life, which complicates Wilson disease screening in very young children. Levels also fluctuate with the menstrual cycle and rise substantially during pregnancy, so interpreting a result always requires context about age, sex, hormonal status, and inflammatory state.
Ceruloplasmin in the Brain
Although the liver is the main production site, ceruloplasmin is also made locally in the brain by astrocytes, the support cells that nourish and protect neurons. Research in mice has shown that deleting ceruloplasmin in astrocytes during early development leads to impaired myelination, the insulating coating that allows nerve signals to travel efficiently. When the same deletion was made in older animals, the result was iron accumulation in the brain, oxidative stress, myelin loss, and eventually behavioral deficits including problems with movement and short-term memory.20PubMed Central. The expression of ceruloplasmin in astrocytes is essential for postnatal myelination and myelin maintenance in the adult brain
These findings help explain why disorders of ceruloplasmin, especially aceruloplasminemia, so often present with neurological symptoms. They also raise questions about whether age-related declines in ceruloplasmin function contribute to neurodegenerative diseases more broadly, though that connection remains speculative. What is clear is that the brain depends on locally produced ceruloplasmin to manage iron safely, and when that system fails, iron becomes toxic to the very cells that need it most.
When Your Doctor Orders the Test
If you are looking at a ceruloplasmin result on your lab report, odds are it was ordered for one of a handful of reasons. The most common is screening for Wilson disease, particularly in young people presenting with unexplained liver problems, psychiatric symptoms, or movement disorders. It also gets ordered when copper deficiency or excess is suspected, sometimes as part of a workup for unexplained anemia (since ceruloplasmin’s iron-handling role means copper problems can masquerade as iron problems), and occasionally to monitor known copper disorders over time.
A low result should prompt further investigation but not panic. Roughly 15% of children tested for Wilson disease in one large study had a false-positive low ceruloplasmin, meaning their levels were below the screening cutoff but they did not have the disease.7PubMed Central. Diagnostic Value of Ceruloplasmin in the Diagnosis of Pediatric Wilson’s Disease Non-Wilson causes like malabsorption, liver disease of other origins, or even just lab variation can explain a low reading. Conversely, a normal ceruloplasmin does not completely exclude Wilson disease, especially in the presence of active inflammation or estrogen use, both of which can artifactually elevate the number into the normal range.
A high result, on the other hand, almost never triggers an urgent workup on its own. It is usually interpreted alongside other inflammatory markers, and the underlying cause is typically already apparent from the clinical picture: an active autoimmune disease, a known infection, pregnancy, or estrogen-containing medication. Persistently elevated ceruloplasmin without an obvious explanation might prompt a closer look at possible malignancy or a smoldering inflammatory condition, but this scenario is uncommon.
A Protein Named for Its Color
Ceruloplasmin’s name traces back to the 1940s, when the Swedish biochemist Carl Holmberg isolated a striking blue-colored protein from blood plasma. He acknowledged earlier observations of a blue serum globulin by other researchers, but it was Holmberg, working with Carl-Bertil Laurell, who characterized the protein and named it coeruloplasmin after the Latin “caeruleus,” meaning sky-blue. The spelling shifted as the term traveled into English-language literature, becoming “ceruloplasmin” in American usage and “caeruloplasmin” in British publications. Despite the evocative name, the protein does not actually turn your blood blue: its concentration in plasma is far too low to produce a visible color change. You need to concentrate it in a test tube before the blue becomes apparent. The name endures as one of the more poetic terms in clinical chemistry, a reminder that the people who first found this molecule were genuinely startled by what they saw in the centrifuge.